Figure 1A. Changes in sirolimus dosage and blood concentration in sirolimus group; B. Changes in the cyclosporine dosage and blood concentration in the cyclosporine group; C. Changes in the mycophenolate mofetil dosage in the sirolimus group and the cyclosporine group; *P < .05 compared between the sirolimus group and the cyclosporine group at the same visit month; #P < .05 compared with baseline in sirolimus group.